NCT04589338

Brief Summary

This is a prospective interventional study. The investigators will include patients in clinical remission who are on stable treatment. These IBD patients will be followed to analyze the effects of physical activity on their inflammatory disease. Different exercises will be offered to two separate groups of randomly distributed patients: the first group will perform muscle building exercises while the other group will be offered aerobic exercises.There will also be a control group that does not initially benefit from a specific physical activity program. However, this group will be integrated into one of the other two groups after the 10-week follow-up. All three groups will perform the same baseline tests. These will be of different types: physical tests, biological tests and quality of life questionnaires.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 22, 2020

Completed
27 days until next milestone

First Posted

Study publicly available on registry

October 19, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

January 5, 2021

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 7, 2023

Completed
Last Updated

May 9, 2023

Status Verified

May 1, 2023

Enrollment Period

1.9 years

First QC Date

September 22, 2020

Last Update Submit

May 8, 2023

Conditions

Outcome Measures

Primary Outcomes (28)

  • Progressive effort test on bicycle ergometer (VO2 max)

    This test allows to measure VO2 in ml/min/kg (thanks to respiratory gases)

    day 1

  • Progressive effort test on bicycle ergometer (VO2 max)

    This test allows to measure VO2 in ml/min/kg (thanks to respiratory gases)

    through study completion, an average of 40 weeks

  • Progressive effort test on bicycle ergometer (Heart rate)

    This test allows to measure resting and maximum heart rate (thanks to an ECG) and maximum aerobic power in Watt.

    day 1

  • Progressive effort test on bicycle ergometer (Heart rate)

    This test allows to measure resting and maximum heart rate (thanks to an ECG) and maximum aerobic power in Watt.

    through study completion, an average of 40 weeks

  • Progressive effort test on bicycle ergometer (Power)

    This test allows to measure maximum aerobic power in Watt.

    day 1

  • Progressive effort test on bicycle ergometer (Power)

    This test allows to measure maximum aerobic power in Watt.

    through study completion, an average of 40 weeks

  • Maximum force test (N/m)

    This test will be performed using an isokinetic dynamometer. This evaluation will allow us to determine the maximum force of the quadriceps and hamstrings of each participant in N/m.

    Day 1

  • Maximum force test (N/m)

    This test will be performed using an isokinetic dynamometer. This evaluation will allow us to determine the maximum force of the quadriceps and hamstrings of each participant in N/m.

    through study completion, an average of 40 weeks

  • Blood sample

    This type of tests includes biological monitoring to obtain information on biological parameters.

    Day 1

  • Blood sample

    This type of tests includes biological monitoring to obtain information on biological parameters.

    through study completion, an average of 40 weeks

  • Saddle analysis

    This type of tests includes biological monitoring to obtain information on biological parameters.

    Day 1

  • Saddle analysis

    This type of tests includes biological monitoring to obtain information on biological parameters.

    through study completion, an average of 40 weeks

  • IBD-F

    Participants will complete a questionnaire on fatigue perceived.

    Week 1

  • IBD-F

    Participants will complete a questionnaire on fatigue perceived.

    Week 10

  • IBD-F

    Participants will complete a questionnaire on fatigue perceived.

    Week 20

  • Godin Leisure Time exercise questionnaire

    Participants will complete a questionnaire on the level of physical activity

    Week 1

  • Metabolic Equivalent Task questionnaire

    Participants will complete a questionnaire on the level of inactivity

    Week 1

  • Metabolic Equivalent Task questionnaire

    Participants will complete a questionnaire on the level of inactivity

    Week 10

  • Metabolic Equivalent Task questionnaire

    Participants will complete a questionnaire on the level of inactivity

    Week 20

  • Short Food Frequency Questionnaire

    Participants will complete a questionnaire on their dietary habits

    Week 1

  • Short Food Frequency Questionnaire

    Participants will complete a questionnaire on their dietary habits

    Week 10

  • Short Food Frequency Questionnaire

    Participants will complete a questionnaire on their dietary habits

    Week 20

  • EQ5D questionnaire

    Participants will complete a questionnaire on their level of health

    Week 1

  • EQ5D questionnaire

    Participants will complete a questionnaire on their level of health

    Week 10

  • EQ5D questionnaire

    Participants will complete a questionnaire on their level of health

    Week 20

  • Short health scale questionnaire

    Participants will complete a questionnaire to evaluate the level of the inflammatory bowel disease

    Week 1

  • Short health scale questionnaire

    Participants will complete a questionnaire to evaluate the level of the inflammatory bowel disease

    Week 10

  • Short health scale questionnaire

    Participants will complete a questionnaire to evaluate the level of the inflammatory bowel disease

    Week 20

Study Arms (3)

Endurance training group

EXPERIMENTAL
Other: Endurance training

Resistance training group

EXPERIMENTAL
Other: Resistance training

Control group

NO INTERVENTION

Interventions

This group will perform aerobic type exercises. Initially, patients will perform continuous exercises of progressive intensity in order to adapt to this kind of effort. Next, we will introduce interval exercises.

Endurance training group

Patients in this group will perform lower limb strengthening exercises to improve the maximum strength of different muscle groups.

Resistance training group

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients in remission defined by a Harvey Bradshaw Index 5 in Crohn's disease (CD) and a clinical Mayo 3 with no sub-score \>1 in ulcerative colitis (RCUH) with stable treatment, without corticosteroid for 4 months.
  • Patients accepting the study protocol

You may not qualify if:

  • Patients suffering from other pathologies (at the level of the digestive system, the cardiovascular system, as well as the musculoskeletal system: recent knee plasty, recent knee fractures, etc.), which can interfere with planned tests and activity programs.
  • Patients with more than 3 hours of sports activity per week
  • Pregnant, pregnant or nursing patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Université de Liège

Liège, 4000, Belgium

Location

MeSH Terms

Conditions

Inflammatory Bowel Diseases

Interventions

Endurance TrainingResistance Training

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 22, 2020

First Posted

October 19, 2020

Study Start

January 5, 2021

Primary Completion

December 15, 2022

Study Completion

February 7, 2023

Last Updated

May 9, 2023

Record last verified: 2023-05

Locations